Sahajanand Medical Technologies Ltd
Sahajanand Medical Technologies to consider Q2 FY27 financials Nov 5
BOARD
● No Immediate Change
LOW RISK
📅 Filed on BSE: 26 Oct 2026, 05:57 PM IST · BSE ID: 0029919b-64b0-45d3-8451-8fa144677148
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board will meet soon to go over the latest financial performance results.
🤖 AI Summary
- Board meeting scheduled for November 5, 2026, to approve financial results.
- Unaudited standalone and consolidated results for Q2 and H1 FY27.
- Results period ends September 30, 2026, with auditor's limited review.
- The meeting will also address any other necessary business matters.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders; await the release of the financial results.
👤
Who Is Affected
All shareholders will be affected by the information contained within the upcoming financial results disclosure.
🔍
Management Signal
Management is adhering to regulatory timelines for the disclosure of financial performance.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List - track these upcoming events
Board meeting on November 5, 2026, for financial result approval.
Release of unaudited standalone financial results for Q2 and H1 FY27.
Release of unaudited consolidated financial results for Q2 and H1 FY27.
LOW RISK
This is a standard procedural filing announcing a future board meeting.
💡 Investor Takeaway
Sahajanand Medical Technologies will announce its unaudited standalone and consolidated financial results for Q2 and H1 FY27 on November 5, 2026, including the auditor's limited review report.
❓ Frequently Asked Questions
When will Sahajanand Medical Technologies announce its Q2 FY27 financial results?
The Board of Directors will consider and approve the unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2026, on November 5, 2026.
What period do the upcoming financial results for Sahajanand Medical Technologies cover?
The results will cover the second quarter and the half year ended September 30, 2026.
What is the purpose of Sahajanand Medical Technologies' board meeting on November 5, 2026?
The board meeting is scheduled to consider and approve the unaudited standalone and consolidated financial results for Q2 and H1 FY27, along with the auditor's limited review report.
Questions based on this BSE filing only. For information purposes.